| RS1208531254 |
NEFL
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS1208569498 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS1208575764 |
FLT3
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1208593429 |
PUS3
|
Health Risk |
Likely pathogenic |
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome |
| RS1208611147 |
RNU4ATAC
|
Health Risk |
Conflicting classifications of pathogenicity |
RNU4ATAC-related spliceosomopathies, RNU4ATAC-related spliceosomopathies |
| RS1208616690 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS1208628241 |
SOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS1208636573 |
MSTO1
|
Health Risk |
Likely pathogenic |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome |
| RS1208636696 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1208652152 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1208669621 |
DNAJC21
|
Health Risk |
Pathogenic |
— |
| RS1208681909 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1208700189 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS1208703297 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1208704909 |
EFEMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Doyne honeycomb retinal dystrophy, Doyne honeycomb retinal dystrophy |
| RS1208715055 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Inborn genetic diseases |
| RS1208723557 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS1208736713 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1208742830 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 4, PSEN2-related disorder |
| RS1208761835 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1208799683 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1208811629 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1208820400 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1208834216 |
MYH14
|
Health Risk |
Pathogenic |
MYH14-related disorder, MYH14-related disorder |
| RS1208838203 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Noonan syndrome and Noonan-related syndrome |
| RS1208845035 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1208849844 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS1208855163 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult hypophosphatasia, Hypophosphatasia |
| RS1208873596 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1208879197 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1208909878 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1208927738 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS1208934708 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1208949378 |
TCF20
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1208952914 |
SLC26A3
|
Health Risk |
Pathogenic |
Polyhydramnios, Hydrops fetalis |
| RS1209004897 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1209013786 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1209021925 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1209026051 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1209029221 |
TNFRSF11A
|
Health Risk |
Pathogenic |
— |
| RS1209052568 |
BOLA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple mitochondrial dysfunctions syndrome 2, Multiple mitochondrial dysfunctions syndrome 2 |
| RS1209057640 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1209062363 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS1209068432 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1209071029 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1209087083 |
PIGG
|
Health Risk |
Likely pathogenic |
— |
| RS1209098685 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal carcinoma |
| RS1209104357 |
AGBL5
|
Health Risk |
Pathogenic |
— |
| RS1209105017 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1209123501 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS12091253 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMB3-related disorder, Inborn genetic diseases |
| RS1209130981 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS1209143268 |
ABCG8
|
Health Risk |
Likely pathogenic |
— |
| RS1209147330 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, See cases |
| RS1209154325 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Morquio syndrome |
| RS1209173070 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1209188502 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1209208472 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1209227358 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1209261790 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN-related disorder |
| RS1209266607 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS1209270051 |
PNLIP
|
Health Risk |
Pathogenic |
— |
| RS1209271799 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1209280928 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1209312070 |
SLC19A3
|
Health Risk |
Likely pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1209321050 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1209332250 |
MME
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1209337990 |
TRDN
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1209343108 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1209349503 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS1209357687 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1209379774 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1209384219 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1209386423 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1209389771 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1209393896 |
CERKL
|
Health Risk |
Likely pathogenic |
Stargardt disease, Retinitis pigmentosa 26 |
| RS1209396791 |
TMX2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, cortical malformations |
| RS1209400793 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leydig cell agenesis, Gonadotropin-independent familial sexual precocity |
| RS1209412483 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1209421607 |
CEP290
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 4 |
| RS1209423257 |
MRPL39
|
Health Risk |
Pathogenic |
Leigh syndrome, Combined oxidative phosphorylation deficiency 59 |
| RS1209447028 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1209455991 |
PLXNA3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1209458962 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal renal tubular acidosis |
| RS1209473816 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1209493320 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1209497158 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1209510659 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1209536013 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1209537944 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1209546147 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1209546374 |
DSC2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS1209550754 |
DARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1209551499 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1209582847 |
PNPT1
|
Health Risk |
Likely pathogenic |
— |
| RS1209588647 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS1209593787 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1209605608 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS1209610920 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1209622397 |
HFM1
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |